EE03304B1 - Tsüklodekstriini või selle derivaadi kasutamine mukoadhesiivse ainena, mukoadhesiivne kompositsioon ja meetod selle valmistamiseks - Google Patents

Tsüklodekstriini või selle derivaadi kasutamine mukoadhesiivse ainena, mukoadhesiivne kompositsioon ja meetod selle valmistamiseks

Info

Publication number
EE03304B1
EE03304B1 EE9600212A EE9600212A EE03304B1 EE 03304 B1 EE03304 B1 EE 03304B1 EE 9600212 A EE9600212 A EE 9600212A EE 9600212 A EE9600212 A EE 9600212A EE 03304 B1 EE03304 B1 EE 03304B1
Authority
EE
Estonia
Prior art keywords
mucoadhesive
cyclodextrin
derivative
preparation
composition
Prior art date
Application number
EE9600212A
Other languages
English (en)
Estonian (et)
Inventor
Karel Jozef Fran�ois Marc
Carolus Leonarda Snoeckx Eric
Putteman Peter
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE03304B1 publication Critical patent/EE03304B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)
EE9600212A 1994-05-18 1995-05-10 Tsüklodekstriini või selle derivaadi kasutamine mukoadhesiivse ainena, mukoadhesiivne kompositsioon ja meetod selle valmistamiseks EE03304B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94201402 1994-05-18
PCT/EP1995/001760 WO1995031178A1 (en) 1994-05-18 1995-05-10 Mucoadhesive emulsions containing cyclodextrin

Publications (1)

Publication Number Publication Date
EE03304B1 true EE03304B1 (et) 2000-12-15

Family

ID=8216883

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600212A EE03304B1 (et) 1994-05-18 1995-05-10 Tsüklodekstriini või selle derivaadi kasutamine mukoadhesiivse ainena, mukoadhesiivne kompositsioon ja meetod selle valmistamiseks

Country Status (30)

Country Link
US (1) US5814330A (pl)
EP (1) EP0759741B1 (pl)
JP (1) JP3862748B2 (pl)
KR (1) KR100369703B1 (pl)
CN (1) CN1091590C (pl)
AP (1) AP731A (pl)
AT (1) ATE174790T1 (pl)
AU (1) AU680767B2 (pl)
BG (1) BG62754B1 (pl)
BR (1) BR9507873A (pl)
CZ (1) CZ285606B6 (pl)
DE (1) DE69506857T2 (pl)
DK (1) DK0759741T3 (pl)
EE (1) EE03304B1 (pl)
ES (1) ES2127529T3 (pl)
FI (1) FI964589A0 (pl)
HK (1) HK1010688A1 (pl)
HU (1) HU218082B (pl)
IL (1) IL113742A (pl)
MY (1) MY113846A (pl)
NO (1) NO309507B1 (pl)
NZ (1) NZ285761A (pl)
OA (1) OA10321A (pl)
PL (1) PL179619B1 (pl)
RO (1) RO117145B1 (pl)
RU (1) RU2164418C2 (pl)
SK (1) SK282623B6 (pl)
TW (1) TW438601B (pl)
WO (1) WO1995031178A1 (pl)
ZA (1) ZA954023B (pl)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ324157A (en) * 1995-11-28 2000-10-27 Univ Johns Hopkins Med Conditionally replicating viral vectors and their use in treating HIV
CZ289379B6 (cs) * 1996-10-24 2002-01-16 The Procter & Gamble Company Vodný prostředek absorbující pach, tvarovaný polątářkový prostředek absorbující pach a způsob výroby vodného prostředku absorbujícího pach
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
DE69808670T2 (de) 1997-12-31 2003-07-03 Choongwae Pharma Corp., Seoul/Soul Herstellungsverfahren und zusammensetzung einer oralen zubereitung von itraconazol
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
GB9920167D0 (en) * 1999-08-25 1999-10-27 Avery Dennison Corp Pressure sensitive adhesive compositions
WO2001034213A1 (en) * 1999-11-09 2001-05-17 The Procter & Gamble Company Cyclodextrin compositions for odor, insect and dust mite contol
US6835717B2 (en) * 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
KR100388605B1 (ko) * 2000-06-13 2003-06-25 코오롱제약주식회사 용해도 및 용해속도가 향상된 이트라코나졸의 액상 조성물 및 이를 이용한 이트라코나졸 제제와 그 제조방법
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
ES2314049T3 (es) 2001-02-15 2009-03-16 Access Pharmaceuticals, Inc. Formulaciones liquidas para la prevencion y el tratamiento de enfermedades y trastornos de la mucosa.
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
DK2060259T3 (da) * 2001-11-01 2010-05-17 Spectrum Pharmaceuticals Inc Medicinske sammensætninger til intravesikal behandling af blærecancer
US8563592B2 (en) 2001-11-01 2013-10-22 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment and methods
CN100384865C (zh) * 2001-11-02 2008-04-30 嵌入治疗公司 用于rna干扰的治疗用途的方法及组合物
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
US20030144362A1 (en) * 2002-01-28 2003-07-31 Utterberg David S. High viscosity antibacterials for cannulae
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
US6824763B2 (en) 2002-05-30 2004-11-30 Kimberly-Clark Worldwide, Inc. Anti-fungal powder having enhanced excipient properties
US7977532B2 (en) 2002-09-05 2011-07-12 The Procter & Gamble Company Tampon with clean appearance post use
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
US20050095245A1 (en) * 2003-09-19 2005-05-05 Riley Thomas C. Pharmaceutical delivery system
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
BRPI0518999A2 (pt) 2004-12-10 2008-12-23 Talima Therapeutics Inc composiÇÕes e mÉtodos para tratar condiÇÕes da unidade da unha
MX2007013631A (es) * 2005-05-09 2008-01-24 Drugtech Corp Composiciones farmaceuticas de liberacion modificada.
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP1968544A2 (en) * 2006-01-05 2008-09-17 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
JP2009522360A (ja) * 2006-01-05 2009-06-11 ドラッグテック コーポレイション 組成物およびその使用方法
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
JP2011503073A (ja) 2007-11-13 2011-01-27 メリテイジ ファーマ，インク． コルチコステロイド組成物
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
KR20130097813A (ko) 2008-04-21 2013-09-03 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
AU2009274229B2 (en) 2008-07-21 2013-08-22 Otonomy, Inc. Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
ES2811051T3 (es) 2008-08-20 2021-03-10 Univ California Corticosteroides para el tratamiento de enfermedades inflamatorias del tracto gastrointestinal
BR112015022025A8 (pt) 2013-03-14 2019-12-10 Hallux Inc composição e uso de um agente ativo
BR112018001900A2 (pt) 2015-07-28 2018-09-18 Otonomy, Inc. composições agonistas de trkb ou trkc e métodos para o tratamento de condições óticas
JP7033789B2 (ja) 2016-06-29 2022-03-11 オトノミー，インク． トリグリセリド耳用製剤とその使用
WO2019154895A1 (en) 2018-02-08 2019-08-15 Strekin Ag Gel formulation for preventing or treating hearing loss

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
EP0335545B2 (en) * 1988-03-29 1998-09-23 University Of Florida Pharmaceutical formulations for parenteral use
US5055303A (en) * 1989-01-31 1991-10-08 Kv Pharmaceutical Company Solid controlled release bioadherent emulsions
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
DK0625899T3 (da) * 1992-02-12 1996-06-17 Janssen Cilag S P A Liposom-itraconazolformuleringer
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
FR2719999B1 (fr) * 1994-05-17 1996-08-02 Georges Serge Grimberg Composition pharmaceutique à base de gomme de guar et d'un antiacide neutralisant, à laquelle peut être ajoutée une série de principes actifs thérapeutiques.

Also Published As

Publication number Publication date
FI964589A (fi) 1996-11-15
RU2164418C2 (ru) 2001-03-27
AP9600873A0 (en) 1996-10-31
KR100369703B1 (ko) 2003-04-16
BR9507873A (pt) 1997-09-23
PL317257A1 (en) 1997-04-01
RO117145B1 (ro) 2001-11-30
ATE174790T1 (de) 1999-01-15
CN1148335A (zh) 1997-04-23
IL113742A (en) 1999-09-22
NO309507B1 (no) 2001-02-12
OA10321A (en) 1997-10-07
HUT76326A (en) 1997-08-28
EP0759741A1 (en) 1997-03-05
BG62754B1 (bg) 2000-07-31
DE69506857T2 (de) 1999-08-05
AU2526495A (en) 1995-12-05
NZ285761A (en) 1997-05-26
US5814330A (en) 1998-09-29
BG100955A (en) 1998-04-30
HU9603188D0 (en) 1997-01-28
NO964853D0 (no) 1996-11-15
CZ285606B6 (cs) 1999-09-15
CZ336996A3 (en) 1997-02-12
IL113742A0 (en) 1995-08-31
ES2127529T3 (es) 1999-04-16
AP731A (en) 1999-02-08
DK0759741T3 (da) 1999-08-23
KR970702719A (ko) 1997-06-10
ZA954023B (en) 1996-11-18
WO1995031178A1 (en) 1995-11-23
TW438601B (en) 2001-06-07
CN1091590C (zh) 2002-10-02
SK282623B6 (sk) 2002-10-08
EP0759741B1 (en) 1998-12-23
NO964853L (no) 1996-11-15
AU680767B2 (en) 1997-08-07
DE69506857D1 (de) 1999-02-04
SK146996A3 (en) 1997-05-07
FI964589A0 (fi) 1996-11-15
JPH10500121A (ja) 1998-01-06
PL179619B1 (pl) 2000-10-31
MY113846A (en) 2002-06-29
JP3862748B2 (ja) 2006-12-27
HU218082B (hu) 2000-05-28
HK1010688A1 (en) 1999-06-25

Similar Documents

Publication Publication Date Title
EE03304B1 (et) Tsüklodekstriini või selle derivaadi kasutamine mukoadhesiivse ainena, mukoadhesiivne kompositsioon ja meetod selle valmistamiseks
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
EE05086B1 (et) Primidiini derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, kombinatsioon ning saadus
BR9500555A (pt) Composição cosméticas de uso tópico,processo de preparação de composições,utilização de composições e processo de tratamento cosmético
FI103704B1 (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
EE200000596A (et) Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
FI972309A0 (fi) 2-heterosyklyylioksi- ja tiometyyli-1,2,5-tiaditsolidin-3-oni-1,1-dioksideja, niitä sisältäviä koostumuksia ja menetelmä niiden valmistamiseksi
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE04717B1 (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
EE9800200A (et) Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE200100314A (et) Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
EE200000767A (et) Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
FI964031A (fi) Bentsamidijohdannainen, mainittua johdannaista sisältävät koostumukset ja sen käyttö
EE04346B1 (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE200000099A (et) Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode
FI972306A0 (fi) Substituoituja 2-aryylikarbonyylioksimetyyli-1,2,5-tiadiatsolidin -3- oni-1,1-dioksidi-johdannaisia ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
FI944182A0 (fi) Yhtenäiskiteitä sisältävä koostumus, menetelmä senYhtenäiskiteitä sisältävä koostumus, menetelmä sen valmistamiseksi ja sen käyttö valmistamiseksi ja sen käyttö
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
FI956278A (fi) Substituoituja 4-fenyylitiatsolijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
FI960316A (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine
EE200100209A (et) Tritsüklilised 3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
EE9600180A (et) Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamine
EE04680B1 (et) Tritsklilised 3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20080510